AI assistant
Sending…
TG THERAPEUTICS, INC. — Director's Dealing 2021
Feb 12, 2021
31066_dirs_2021-02-12_6662f9a3-ecac-45f8-8ebc-148ae8509594.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2020-12-31
Reporting Person: Power Sean A (CFO, Secretary and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-10-09 | COMMON STOCK | G | 125000 | — | Disposed | 636438 | Direct |
| 2020-12-21 | COMMON STOCK | G | 7000 | — | Disposed | 629438 | Direct |
Footnotes
F1: Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust.
F2: Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization.
F3: Includes 107,500 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing.
More from TG THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 3
Regulatory Filings
2026
May 27
Earnings Release
2026
May 6
Capital/Financing Update
2026
Mar 20
Annual Report
2026
Feb 27
Earnings Release
2026
Feb 26
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 13
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9